Muscle-specific cell ablation conditional upon Cre-mediated DNA recombination in transgenic mice leads to massive spinal and cranial motoneuron loss.
We describe here a binary transgenic system based on Cre-mediated DNA recombination for genetic cell ablation in mice that enabled us to obtain skeletal muscle-deficient embryos by mating two phenotypically normal transgenic lines. In those embryos, skeletal muscles are eliminated as a consequence of the expression of the gene encoding the diphtheria toxin A fragment. Cell ablation occurs gradually beginning approximately on embryonic day (E) 12.5, and by E18-5 almost all skeletal muscle is absent. Analysis of the consequences of muscle cell ablation revealed that almost all spinal motoneurons are lost by E18.5, providing strong evidence that survival of spinal motoneurons during embryogenesis is dependent on signals from their target tissue, skeletal muscle, and that trophic signals produced by nonmuscle sources are sufficient to support survival of no more than 10% of embryonic spinal motoneurons in the absence of muscle-derived signals. There was also substantial loss of cranial (hypoglossal and facial) motoneurons in the muscle-deficient embryos, thus indicating that cranial motoneuron survival is also dependent on trophic signals produced by their target tissue. Although spinal motoneurons are a major target of spinal interneurons, the loss of motoneurons did not affect interneuron survival. Muscle-deficient embryos had a cleft palate and abnormalities of the lower jaw, raising the possibility that they might serve as a mouse model for the human disorder, Robin sequence. The data reported here demonstrate the utility of a binary transgenic system for obtaining mouse embryos in which a specific cell population has been ablated, so that its role in embryonic development can be studied.
Grieshammer
U
U
Department of Anatomy, School of Medicine, University of California, San Francisco 94143-0452, USA.
Lewandoski
M
M
Prevette
D
D
Oppenheim
R W
RW
Martin
G R
GR
D000818:Animals; D017209:Apoptosis / Q000235:genetics*; D001483:Base Sequence; D001921:Brain / Q000002:abnormalities / Q000166:cytology / Q000196:embryology; D004274:DNA, Recombinant / Q000235:genetics*; D004167:Diphtheria Toxin / Q000235:genetics; D005260:Female; D006801:Humans; D019426:Integrases / Q000235:genetics / Q000378:metabolism; D007395:Interneurons / Q000166:cytology; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D008954:Models, Biological; D009046:Motor Neurons / Q000166:cytology*; D018482:Muscle, Skeletal / Q000002:abnormalities / Q000196:embryology* / Q000294:innervation; D018008:Myogenin / Q000235:genetics; D010446:Peptide Fragments / Q000235:genetics; D011995:Recombination, Genetic; D015398:Signal Transduction; D013116:Spinal Cord / Q000002:abnormalities / Q000166:cytology / Q000196:embryology; D014764:Viral Proteins
D004274:DNA, Recombinant; D004167:Diphtheria Toxin; C503799:MYOG protein, human; C503801:Myog protein, mouse; D018008:Myogenin; D010446:Peptide Fragments; D014764:Viral Proteins; C029795:diphtheria toxin fragment A; C045073:Cre recombinase; D019426:Integrases